Blood Advances
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo-CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, SVH 2023 guidelines for diagnosis of venous thromboembolism and management in children and pregnant women in Latin America.
1:1.
2023-01-01
-
Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
00:00-2022009179.
2023-01-01
-
Differential prognosis of single and multiple abnormalities in high count MBL and untreated CLL.
1:In press.
2023-01-01
-
Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence.
.:1-1.
2023-01-01
-
Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee.
7:4323-4326.
2023-01-01
-
Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe.
7:1976-1986.
2023-01-01
-
Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.
7:3079-3057.
2023-01-01
-
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line , , and variants.
x:x.
2023-01-01
-
Targeted therapy with nanatinostat and valganciclovir in recurrent Epstein-Barr virus-positive lymphoid malignancies: a Phase 1b/2 study.
1:1.
2023-01-01
-
Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what's new?.
1.
2023-01-01
-
Use of letermovir in umbilical cord blood transplantation based on risk scores.
7:4315-4318.
2023-01-01
-
ASH, ABHH, ACHO, Grupo CAHT, Grupo-CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2022 Guidelines for Prevention of Venous Thromboembolism in Surgical and Medical Patients and Long-Distance Travelers in Latin America.
1:1.
2022-01-01
-
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations.
6:4357-4359.
2022-01-01
-
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19.
1:1-1.
2022-01-01
-
Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study.
6:976-992.
2022-01-01
-
Ibrutinib plus RICE/RVICI for R/R mature B-NHL in children/young adults: SPARKLE trial.
7:602-610.
2022-01-01
-
Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19.
-:--5099.
2022-01-01
-
Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment.
1:1-10.
2022-01-01
-
13q12.2 deletions and FLT3 overexpression in acute leukemias.
5:2075-2078.
2021-01-01
-
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.
5:640-648.
2021-01-01
-
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
5:301-325.
2021-01-01
-
ASH, ABHH, ACHO, Grupo CAHT, Grupo- CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America.
5:3032-3046.
2021-01-01
-
Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature.
6:228-237.
2021-01-01
-
HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment.
5:167-175.
2021-01-01
-
IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanisms.
5:3776-3788.
2021-01-01
-
Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context.
5:3047-3052.
2021-01-01
-
Physiological IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia.
00:00-3646.
2021-01-01
-
Plasma levels of von Willebrand Factor and future risk of incident venous thromboembolism.
5:224-232.
2021-01-01
-
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data.
2021:2021004710.
2021-01-01
-
Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism.
5:2237-2244.
2021-01-01
-
Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel.
5:4855-4863.
2021-01-01
-
von Willebrand disease: proposing definitions for future research.
5:565-569.
2021-01-01
-
An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.
4:4679-4692.
2020-01-01
-
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines.
4:1512-1517.
2020-01-01
-
Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.
4:3990-4006.
2020-01-01
-
Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1.
4:2018-2031.
2020-01-01
-
Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia.
4:2339-2350.
2020-01-01
-
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseases.
4:6327-6335.
2020-01-01
-
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
4:5951-5957.
2020-01-01
-
Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.
4:1102-1114.
2020-01-01
-
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.
4:4929-4944.
2020-01-01
-
Systematic Review and Meta-Analysis of Outcomes in Patients with Suspected Deep Vein Thrombosis.
4:2779-2788.
2020-01-01
tem uma área de assunto
publisher
-
American Society of Hematology
is open access
-
True
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S2764683450
International Standard Serial Number (ISSN)